Mason Miller is a cancer biologist with a passion for developing next-generation therapies for pediatric patients. He earned his B.S. in Molecular and Cellular Biology with a minor in Classical Studies from the University of Louisville, where he also gained formative experience working as a lab technician—a role that sparked his deep appreciation for the research process and its transformative potential.
Miller’s research has focused on targeted protein degradation for RAS-driven pancreatic cancers. As part of the Brown Cancer Center’s R25 Summer Research Program and a UL-BIOMED PREP Scholar, he worked on designing PROTACs (proteolysis targeting chimeras) to dismantle oncogenic proteins, paving the way for novel therapeutic strategies. His scientific interests are grounded in drug development and pharmacology, with the goal of translating discovery into cures for patients facing catastrophic diseases.
He joined the Biomedical Sciences Ph.D. program at the St. Jude Graduate School to receive rigorous, hands-on training from world-class scientists at an institution renowned for pioneering research in pediatric cancer. At St. Jude, Miller is excited to contribute to the mission of transforming outcomes for children through bold, data-driven innovation.
Hometown: Louisville, KY
Education:
2024 - BS, Molecular and Cell Biology (Minor in Classical Studies) - University of Louisville
Awards/Honors/Scholarships:
2024 - UL-BIOMED PREP Scholar – University of Louisville
2023 - R25 Summer Research Program – Brown Cancer Center
2021, 2023 - Dean’s List – University of Louisville
2022 - Dean’s Scholar – University of Louisville